OTC

Strength

325; 2; 5 mg/1; mg/1; mg/1

NDC

70677100401

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

4/25/2023

Pharmacological Classes

Adrenergic alpha1-Agonists
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

-1.0%

3M

+0.4%

6M

-2.9%

1Y

-2.9%

3Y

N/A

5Y

N/A

All

+6.7%